These findings suggest that, in a predominantly sporadic ALS cohort, serum Cf-mtDNA may not serve as a standalone diagnostic or prognostic biomarker, in contrast to previous reports. The gene discussed is CFTR; the disease is amyotrophic lateral sclerosis.